TRADE ALERT: Tesla, Genus and Avast trading instructions

5th February 2020 | Eoin Treacy

Action to take: place at stop on Tesla at $800
Recommended at: $346.41

Action to take: sell Genus
Recommended at: 2,682p
Sold at: 3,112p
Profit: 16.03%

Tesla

I want to thank subscribers for their fortitude in sticking with Tesla despite the negative commentary, not least from a number of my colleagues over the last year. The reason I recommended the share is because I believe the transportation sector is among the most likely to be the subject of disruptive change over the coming decade and we are only at the beginning of that trend.

The reason I am writing to you now is because Tesla has risen in a stratospheric manner over the last couple of weeks. The share gave up $92 of its gain in the last hour of trading on Tuesday and now is the time to introduce a stop. It might yet continue higher so I am recommending a stop instead of selling.

That ensures a gain of more than 100%. In the event we see a significant retracement of the recent gain, I will use that as an opportunity to re-enter the position but I do not wish to forego the opportunity to take a profit of that size.

Genus

I recommending you sell Genus. We bought the share on the argument that it has a solution to the African swine fever in pigs and that it would see growth as a result. News this week that a team from the US Department of Agriculture has successfully developed a vaccine for the disease negates the investment argument for Genus and therefore we should sell.

Avast

Avast announced last week that it is shutting down Jumpshot, the company’s data analytics arm, because it has been found to be selling client browser history to advertisers like Pepsi, Google and Microsoft. The company has apologised and the share bounced over the last couple of days from the region of the trend mean. As long as it is holding the region of the trend mean I am willing to give the share the benefit of the doubt.

All the best,

Eoin Treacy
Investment Director, Frontier Tech Investor

Subscribe Now
Show Sitemap
PUBLICATIONS
USEFUL LINKS
SOUTHBANK INVESTMENT RESEARCH

You don’t need more information to be a better, more profitable investor. You need better research. Here you’ll find investment ideas and strategies from some of Britain’s most experienced investors produced specifically for investors like you. Learn more about independent stock market research and advice from one of the UK’s oldest financial publishers.

  • Save
  • Print

Important Risk Warning

Advice in Altucher’s Investment Network Pro UK does not constitute a personal recommendation.

Any advice should be considered in relation to your own circumstances, risk tolerance and investment objectives. Before investing you should carefully consider the risks involved, including those described below. If you have any doubt as to suitability or taxation implications, seek independent financial advice.

General – Your capital is at risk when you invest, never risk more than you can afford to lose. Past performance and forecasts are not reliable indicators of future results. Bid/offer spreads, commissions, fees and other charges can reduce returns from investments. There is no guarantee dividends will be paid.

Small cap shares - Shares recommended may be small company shares. These can be illiquid meaning they are hard to trade and can have a large bid/offer spread. If you need to sell soon after you bought, you might get back less that you paid. This makes them riskier than other investments in larger share companies.

Overseas investments - Shares may be denominated in a currency other than sterling. The return from these may increase or decrease as a result of currency fluctuations. Any dividends will be taxed at source in the country of issue.

Unregulated investments - The Financial Conduct Authority does not regulate certain activities, including the buying and selling of commodities. This means that you will not have the protection of the Financial Ombudsman Service or the Financial Services Compensation Scheme.

Taxation – Profits from share dealing are a form of income and subject to taxation. Tax treatment depends on individual circumstances and may be subject to change.

Managing Editor: Sam Volkering. Editors or contributors may have an interest in shares recommended. Information and opinions expressed do not necessarily reflect the views of other editors/contributors of Southbank Investment Research Limited.

Full details of our complaints procedure, privacy policy and terms and conditions can be found at, www.southbankresearch.com.

Altucher’s Investing Network PRO UK is published in the UK with licenced content from Paradigm Press LLC. It contains regulated content and is issued by Southbank Investment Research Limited. Registered in England and Wales No 9539630. VAT No GB629 7287 94. Registered Office: Basement, 95 Southwark Street, London, SE1 0HX.

Contact Us: To contact customer services, please call us on 0203 966 4580, Monday to Friday, 10.00am – 5.00pm.

Southbank Investment Research Limited is authorised and regulated by the Financial Conduct Authority. FCA No 706697. https://register.fca.org.uk/.

© 2025 Southbank Investment Research Limited.

Registered in England Company No 9539630. VAT No GB629 7287 94. Registered Office: Basement, 95 Southwark Street, London SE1 0HX.

Southbank Investment Research Limited is authorised and regulated by the Financial Conduct Authority. FCA No 706697 https://register.fca.org.uk/

© 2026 Southbank Investment Research Ltd.